|
Compound | Animal model | Type of assessment | Administration route | Behavioral changes | Hematological changes | Biochemical changes | Histopathological changes | References |
|
1′-S-1′- acetoxychavicol acetate | Sprague-Dawley rats | Acute and 28-day subacute toxicity | Intravenous | No lethality or behavioural changes | All the haematological parameters, were within normal ranges | Significant increase in total protein, albumin and globulin | Mild focal inflammation of kidneys and lobular hepatitis | [148] |
Genistein | Wistar rats | Acute, subchronic, and chronic toxicity | Oral | Slightly decreased food consumption and body weight at the highest doses | Decrease in RBCs at the high doses with an increase in reticulocytes. | A slight increase in gamma glutamyl transferase at the high doses | No treatment-related histopathological changes in these studies | [149] |
Genistein | Swiss albino mice | Acute toxicity | Intraperitoneal | Not assessed | Not assessed | Elevated ALT, AST, and ALP levels | Degenerated liver tissue and hepatotoxicity | [150] |
Thymoquinone-loaded nanostructured lipid carrier | Sprague Dawley rats | Acute toxicity | Intravenous | No significant changes in body weight, food intake. | No changes were reported | No significant differences in ALP, ALT, creatinine, urea, total protein, albumin and total bilirubin | Sec-tions of kidneys and liver showed no abnormality/alterations | [151] |
Thymoquinone | Swiss albino mice | Acute and sub-chronic toxicity study | Oral | Hypoactivity and difficulty in respiration at high doses | Increase in urea and creatinine. Significant decrease in fasting plasma glucose level | Increase in ALT, lactate dehydrogenase, and creatine phosphokinase | Significant reduction in tissue (liver, kidneys, and heart) | [152] |
Ursolic acid | Han–Wistar rats | Repeated dose (90 days) toxicity | Oral | No toxicological changes were observed | Platelet count was significantly increased in comparison with the control. No other changes were observed | No changes | No changes | [153] |
Ursolic acid | Swiss mice | 28-day toxicity | Oral | No changes | Ursolic acid revealed elevated neutrophil count. Urea elevation | Not assessed | Alterations in the architecture of the liver, kidney, and spleen tissues | [154] |
|